10 / July / 2026 Cancer treatments advance, but clinical trials lack diversity Most drugs are tested on populations from wealthy countries—expanding participation to other regions could make therapies more effective for different patient profiles Por Gabriela Monteiro
08 / July / 2026 Brazil a potential global leader in cell and gene therapies, says Martin Bonamino INCA researcher discusses the challenges of using CAR-T cells, how access could be expanded through Brazil’s public health system (SUS), and the potential of gene editing to transform medicine Por Moura Leite Netto
01 / July / 2026 El Niño 2026 raises concerns in Brazil Technical note predicts a high likelihood of the phenomenon developing in the second semester, putting extreme heat, droughts, flooding, and Brazil’s public health preparedness in the spotlight. Por Bruno de Pierro
23 / June / 2026 Deprescribing: a growing trend in elderly care Recent studies examine when discontinuing antihypertensives, statins, and other medications may reduce risks for elderly, frail, or polymedicated patients Por Samuel Antenor
18 / June / 2026 Experimental drug reduces risk of second stroke by 26% International clinical trial involving Brazilian researchers tested asundexian in patients following ischemic stroke Por Gilberto Stam
16 / June / 2026 Electroacupuncture may help treat chemotherapy-induced pain Phase 3 study presented at the ASCO Annual Meeting evaluates the technique as a nonpharmacological alternative for peripheral neuropathy in cancer patients Por Samuel Antenor
12 / June / 2026 “An endangered species”: what is driving physician-scientists out of science? Survey of 230 US professionals finds that 49% are considering leaving research, for reasons beyond lack of funding Por Gilberto Stam
10 / June / 2026 Cancer clinical trials grow more slowly than expected in Brazil, study finds A 20-year analysis shows that the country has made progress but still faces regulatory and cultural barriers, as well as reliance on the pharmaceutical industry. Por Gabriela Monteiro
09 / June / 2026 Butantan dengue vaccine: why rigorous testing cannot predict all rare effects After precautionary suspension by the Ministry of Health, Einstein researcher explains how randomized clinical trials and post-approval surveillance work Por Editorial staff
09 / June / 2026 Global health challenges and their impacts on innovation and equity A funding proposal aimed at the development of vaccines, diagnostics, and accessible therapies seeks to put the Global South at the forefront of health innovation Por Sue Ann Costa Clemens
